PaxVax Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine
PRESS RELEASE Menlo Park, Calif., – September 6, 2013 – PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it More...
CDC issues outbreak notice for travelers to Haiti
The ongoing cholera outbreak that began in over two years ago on the Caribbean nation of Haiti has exceeded 600,000 cases since the epidemic started, prompting the US Centers for Disease Control and Prevention (CDC) More...
